BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26032012)

  • 1. C1q, antibodies and anti-C1q autoantibodies.
    Beurskens FJ; van Schaarenburg RA; Trouw LA
    Mol Immunol; 2015 Nov; 68(1):6-13. PubMed ID: 26032012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1q: a multifunctional ligand for a new immunoadsorption treatment.
    Hiepe F; Pfüller B; Wolbart K; Bruns A; Leinenbach HP; Hepper M; Schössler W; Otto V
    Ther Apher; 1999 Aug; 3(3):246-51. PubMed ID: 10427623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation.
    Dijkstra DJ; van de Bovenkamp FS; Abendstein L; Zuijderduijn R; Pool J; Kramer CSM; Slot LM; Drijfhout JW; de Vor L; Gelderman KA; Rooijakkers SHM; Zaldumbide A; Vidarsson G; Sharp TH; Parren PWHI; Trouw LA
    Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310666120. PubMed ID: 38048459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into the autoimmunogenicity of the complement protein C1q.
    Stoyanova V; Petrova S; Tchorbadjieva M; Deliyska B; Vasilev V; Tsacheva I
    Mol Immunol; 2011 Jan; 48(4):678-82. PubMed ID: 21159384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1q and systemic lupus erythematosus.
    Walport MJ; Davies KA; Botto M
    Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q autoantibodies.
    Kallenberg CG
    Autoimmun Rev; 2008 Sep; 7(8):612-5. PubMed ID: 18606253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.
    Li Q; Ujiie H; Shibaki A; Wang G; Moriuchi R; Qiao HJ; Morioka H; Shinkuma S; Natsuga K; Long HA; Nishie W; Shimizu H
    J Immunol; 2010 Dec; 185(12):7746-55. PubMed ID: 21076071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Structure and function of complement protein C1q and its role in the development of autoimmune diseases].
    Smykał-Jankowiak K; Niemir ZI
    Postepy Hig Med Dosw (Online); 2009 Apr; 63():134-41. PubMed ID: 19373194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
    Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1q, autoimmunity and apoptosis.
    Botto M; Walport MJ
    Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementing antibody profiles: assessing antibody function on antigen microarrays.
    Prechl J; Szittner Z; Papp K
    Immunol Lett; 2012 Mar; 143(1):101-5. PubMed ID: 22306105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus.
    Wisnieski JJ; Jones SM
    J Immunol; 1992 Mar; 148(5):1396-403. PubMed ID: 1538123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation by (auto-) antibodies.
    Daha NA; Banda NK; Roos A; Beurskens FJ; Bakker JM; Daha MR; Trouw LA
    Mol Immunol; 2011 Aug; 48(14):1656-65. PubMed ID: 21757235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional definition of a B cell epitope, KGEQGEPGA, on C1q the Fc-binding subunit of the first component of complement.
    Trinder PK; Märker-Hermann E; Loos M; Maeurer MJ
    Scand J Immunol; 1999 Dec; 50(6):635-41. PubMed ID: 10607312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human C1q with IgG and IgM: revisited.
    Gadjeva MG; Rouseva MM; Zlatarova AS; Reid KB; Kishore U; Kojouharova MS
    Biochemistry; 2008 Dec; 47(49):13093-102. PubMed ID: 19006321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.